SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,957.27 -307.24
( -0.40%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,816.31 23.77
(0.22%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivo Bio Tech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

511509

INE380K01017

41.2789706

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVOBIOT

40.45

EPS(TTM)

Face Value()

Div & Yield %

Back

Kuber Udyog standalone net profit rises 144.44% in the June 2026 quarter

Jul 24,2026

Net profit of Kuber Udyog rose 144.44% to Rs 0.22 crore in the quarter ended June 2026 as against Rs 0.09 crore during the previous quarter ended June 2025. Sales rose 36.00% to Rs 0.34 crore in the quarter ended June 2026 as against Rs 0.25 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.34	0.25	36
OPM %	85.29	60.00	-
PBDT	0.29	0.09	222
PBT	0.29	0.09	222
NP	0.22	0.09	144

76,957.27 -307.24 ( -0.40%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,816.31 23.77 (0.22%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)